BI 6727: all 24 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid TumoursCompletedNCT02273388Phase 1Results posted
- Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaCompletedNCT02201329Phase 1Results posted
- Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)TerminatedNCT02003573Phase 1Results posted
- Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is KnownCompletedNCT01971476Phase 1Results posted
- Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMMLTerminatedNCT01957644Phase 1Results posted
- Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various TumoursCompletedNCT01772563Phase 1Results posted
- Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)CompletedNCT01721876Phase 3Results posted
- Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)CompletedNCT01662505Phase 1Results posted
- An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid TumoursCompletedNCT01206816Phase 1Results posted
- BI 6727 (Volasertib) Human ADME Trial in Various Solid TumoursCompletedNCT01145885Phase 1Results posted
- BI 6727 (Volasertib) Randomised Trial in Ovarian CancerCompletedNCT01121406Phase 2Results posted
- Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial CancerCompletedNCT01023958Phase 2Results posted
- Combination of BI6727 (Volasertib) and BIBF1120 in Solid TumorsCompletedNCT01022853Phase 1Results posted
- BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid TumourCompletedNCT00969761Phase 1Results posted
- Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid CancersCompletedNCT00969553Phase 1Results posted
- Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLCCompletedNCT00824408Phase 2Results posted
- Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid LeukaemiaCompletedNCT00804856Phase 2Results posted
- Volasertib Combined With Induction Chemotherapy in Acute Myeloid LeukemiaWithdrawnNCT02905994Phase 1
- Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell LymphomasWithdrawnNCT02875002Phase 1
- Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWithdrawnNCT02861040Phase 1
- Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCLWithdrawnNCT02757248Phase 1
- A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy FailedWithdrawnNCT02722135Phase 1
- A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid LeukemiaWithdrawnNCT02527174Phase 1
- Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)TerminatedNCT02198482Phase 2